League of Historic American Theatres
Chief Executive Officer at League of Historic American Theatres
Austin Theatre Alliance Feb 2004 - Jun 2011
Chief Executive Officer
Thinkery Nov 1999 - Jan 2004
Vice President Development
Hands on Atlanta May 1998 - Nov 1999
Director Business Development
Project Open Hand Apr 1, 1994 - Apr 1, 1998
Director of Development
Education:
Pepperdine University 1990
Pepperdine University 1988 - 1989
St. Mary's University 1986 - 1988
Bachelors, Bachelor of Arts, Media Studies, Communication
The University of Texas at Austin 1983 - 1985
St. Mary's University, Texas
Saint Mary's University of San Antonio
John Marshall High School
Skills:
Performing Arts Board Development Arts Administration Non Profit Administration Fundraising Volunteer Management Grant Writing Nonprofits Public Speaking Philanthropy Community Outreach Event Planning Event Management Board Relations Annual Giving Stewardship Theatre Marketing Grants
expect to recover quickly with U.S. approval, as it did in Europe once MRI-safe approval was secured there. "We believe the same performance we are seeing in Europe ... portends what we will see in the U.S.," said Dr. Ken Stein, chief medical officer of the cardiac-rhythm management (CRM) division.
Since he bought it in the 1980s, his return from stock price appreciation and dividends received has been terrific, and will likely continue compounding for years to come," said Ken Stein, founder and portfolio manager at Spencer Capital Management.
Ken Stein, MD, chief medical officer at the division of Cardiac Rhythm Management, Boston Scientific, agreed with the panel that the device should not be seen as a first-line therapy. "Patients who are doing well on oral anti coagulation, patients who are anticipated to continue doing well on antico
Date: Oct 09, 2014
Category: Health
Source: Google
Boston Scientific's Stroke Device Shows Mixed Results
Boston Scientific plans to submit the findings, plusupdated results from its initial Protect AF trial and otherresearch, to the U.S. regulators to support Watchmans approval,said Ken Stein, chief medical officer of the companys cardiacrhythm management group.
Date: Mar 11, 2013
Category: Health
Source: Google
Boston Scientific's Ingenio Pacemaker Wins US FDA Approval
It has a lot of new features that put us squarely evenwith and, in important respects, ahead of what the competitioncan offer, said Ken Stein, chief medical officer for BostonScientifics cardiac rhythm management group, by telephone. Weare starting to deliver on the product turnaround and a
Date: May 07, 2012
Category: Health
Source: Google
Boston Scientific to Buy Cameron for New Heart Device in $1.35 Bln Deal
The weak link of defibrillator systems to date has beenthe lead that goes into the heart, Ken Stein, chief medicalofficer for Boston Scientifics cardiac rhythm management group,said today. The heart beats approximately 100,000 times a day.Thats a lot of mechanical stress. If you are a young
Date: Mar 09, 2012
Category: Health
Source: Google
Googleplus
Ken Stein
Work:
New York City Department of Education - Teacher
Education:
City-As-School High School, Lehman College, Harry S Truman High School